Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEWJH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,782
Award facts
- Contract value 100% obligated
- $26,781.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, valued at $26,781.78, operates under a firm fixed-price arrangement with an ultimate completion date of May 1, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company holds a significant competitive position within the federal pharmaceutical vendor landscape, with its SPE2DX contract serving as a primary vehicle for delivering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This particular delivery order for Biktarvy, an antiretroviral medication, reflects AmerisourceBergen's ongoing role in supplying essential pharmaceuticals to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEWJH?
SPE2DB25FEWJH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 30, 2025.
How much is contract SPE2DB25FEWJH worth?
The government has obligated $26,782 on SPE2DB25FEWJH.
Is contract SPE2DB25FEWJH an order under another contract?
Yes. SPE2DB25FEWJH is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEWJH competed?
The extent of competition for SPE2DB25FEWJH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award